Mosca, L, Ferris, A, Fabunmi, R, Robertson, RM. Tracking women’s awareness of heart disease: An American Heart Association National Study. Circulation. Available at: www.circulationha.org. DOI: 10.1161/01.CIR.0000115222.69428.C9 2004; Feb 4; 573–579. (Accessed Nov. 17, 2014.)CrossRefGoogle Scholar

Mosca, L, Linfante, AH, Benjamin, EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. Available at: www.circulationha.org. DOI: 10.1161/01.CIR0000154568.43333.82 2005; 111: 499–510. (Accessed Nov. 17, 2014.)CrossRefGoogle ScholarPubMed

Abuful, A, Gidron, Y, Henkin, Y. Physicians’ attitudes toward preventive therapy for coronary artery disease: Is there a gender bias? Clin Cardiol 2005 Aug;28: 389–393.CrossRefGoogle Scholar

Rosamond, W, Flegal, K, Furie, K, et al. (Writing group). Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. Available at: http://circ.ahajournals.org. DOI: 10.1161/CIRCULATIONAHA.107.187998. 2008; 117: e25–e146. (Accessed Nov. 17, 2014.)Google ScholarPubMed

Kim, AM, Tingen, CM, Woodruff, TK. Sex bias in trials and treatment must end. Nature 2010 June 10; 465: 688–689.CrossRefGoogle ScholarPubMed

Mosca, L, Benjamin, EJ, Berra, K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 Update: A guideline from the American Heart Association. J Am Coll Cardiol 2011 Mar 22; 57(12): 1404–1423. DOI:10.1016/j.jacc.2011.02.005.CrossRefGoogle ScholarPubMed

WomenHeart: The National Coalition for Women with Heart Disease. Women & Heart Disease Fact Sheet. Available at: www.womenheart.org/resources.cvdfactsheet.cfm. (Accessed Nov. 20, 2014.)Google Scholar

Gotto, AM, Moon, JE. Management of cardiovascular risk: the importance of meeting lipid targets. Am J Cardiol 2012; 110(suppl): 3A–14A.CrossRefGoogle ScholarPubMed

Wenger, NK. Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association guidelines. Adv Chronic Kidney Dis 2013 Sep; 20(5): 419–422.CrossRefGoogle ScholarPubMed

Puurunen, J, Piltonen, T, Puukka, K, et al. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2013 Dec; 98(12): 4798–4807.CrossRefGoogle ScholarPubMed

Spracklen, CN, Smith, CJ, Saftlas, AF, et al. Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. Am J Epidemiol 2014 Aug; 180(4): 346–358.CrossRefGoogle ScholarPubMed

Mosca, L, Benjamin, EJ, Berra, K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011update: a guideline from the American Heart Association. Circulation 2011; 123(11): 1243–1262.CrossRefGoogle ScholarPubMed

Roberts, JM, August, PA, Bakris, G, et al. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists’ task force in hypertension in pregnancy. Obstet Gynecol 2013 Nov; 122(5): 1122–1131.Google Scholar

US Preventive Services Task Force. Lipid disorders in adults (cholesterol, dyslipidemia): screening. Recommendation Summary. September 2014. Available at: www.uspreventiveservicestaskforce/Page/Topic/recommendation-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening. (Accessed Dec. 30, 2014).Google Scholar

American Academy of Family Physicians. Summary of recommendations for clinical preventive services. November 2014. Available at: www.aafp.org/dam/AAFP/documents/patient_care/clinical_recommendations/cps-recommendations.pdf. (Accessed Dec. 30, 2014).Google Scholar

The American College of Obstetricians and Gynecologists. Well-woman care: assessments & recommendations. July 2013. Available at: www.acog.org/-/media/Departments/Annual-Womens-Health-Care/PrimaryAndPreventiveCare.pdf. (Accessed Dec. 30, 2014).Google Scholar

Daniels, SR, Greer, FR, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008; 122: 198–208.CrossRefGoogle ScholarPubMed

National Institute for Health and Care Excellence. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE Clinical Guideline 181 2014 July; 1–50.Google Scholar

Jellinger, PS, Smith, DA, Mehta, AE, et al. American Association of Clinical Endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012; 18(suppl 1): 1–77.CrossRefGoogle Scholar

Stone, NJ, Robinson, J, Lichtenstein, AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2013 Nov. Available at: http://circ.ahajournals.org/content/early2013/11/11/11/01.cir.0000437738.63852.7a. citation. (Accessed May 15, 2015.)Google Scholar

World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Contraception 1998; 57: 315–324.CrossRefGoogle Scholar

Kemmeren, JM, Tanis, BC, van den Bosch, MAAJ, et al. Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke 2002; 33: 1202–1208.CrossRefGoogle ScholarPubMed

Tanis, BC, van den Bosch, MAAJ, Kemmeren, JM, et al. Oral Contraceptives and the risk of myocardial infarction. N Engl J Med 2001 Dec; 345(25): 1787–1793.CrossRefGoogle ScholarPubMed

Berenson, AB, Rahman, M, Wilkinson, G. Effect of injectable and oral contraceptives on serum lipids. Obstet Gynecol 2009 Oct; 114(4): 786–94.CrossRefGoogle ScholarPubMed

Fotherby, K. Oral contraceptives and lipids. BMJ. 1989; 298(6680): 1049–1050.CrossRefGoogle ScholarPubMed

Sorensen, MB, Collins, P, Ong, PJL, et al. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation 2002; 106: 1646–1651.CrossRefGoogle ScholarPubMed

Bassuk, SS, Manson, JE. Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification. Clin Chem. 2014; 60(1): 68–77.CrossRefGoogle ScholarPubMed

Rossouw, JE, Prentice, RL, Manson, JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465–1477.CrossRefGoogle ScholarPubMed

Goldberg, AC, Hopkins, PN, Toth, PP, et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association expert panel on familial hypercholesterolemia. J Clin Lipidol 2011; 5: S1–S8.CrossRefGoogle Scholar

Youngblom, E, Knowles, JW. Familial hypercholesterolemia. 2014 Jan 2. In: Pagon, RA, Adam, MP, Ardinger, HH, et al., editors. GeneReviews© [Internet]. Seattle, WA: University of Washington, Seattle; 1993–2014. Available from: www.ncbi.nlm.nih.gov/books/NBK174884. (Accessed Dec. 29, 2014.)Google Scholar

Hovingh, GK, Davidson, MH, Kastelein, JJP, O’Connor, AM. Diagnosis and treatment of familial hypercholesterolaemia. Eu Heart J 2013; 34: 962–971.CrossRefGoogle ScholarPubMed

Hopkins, PN, Toth, PP, Ballantyne, CM, Rader, DJ. Familial hypercholesterolemia: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association expert panel on familial hypercholesterolemia. J Clin Lipidol 2011; 5: S9–S17.CrossRefGoogle Scholar

Goldberg, AC, Robinson, JG, Cromwell, WC, et al. Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert panel on familial hypercholesterolemia. J Clin Lipidol 2011; 5: S46–S51.CrossRefGoogle Scholar

Yudi, M, Omera, L, McCubbery, N, et al. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease. Singapore Med J 2012; 53(3): 174–178.Google ScholarPubMed

Harada-Shiba, M, Arai, H, Oikawa, S, et al. Guidelines for the management of famiulial hypercholesterolemia. J Atheroscler Thromb 2012; 19: 1043–1060.CrossRefGoogle ScholarPubMed

Talmud, P, Shah, S, Whittall, R, Futema, M, Howard, P, Cooper JA et al. Use of low density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet 2013; 381: 1293–1301.CrossRefGoogle Scholar

Eckel, RH, Jakicic, JM, Ard, JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014; 129(suppl 2): S76–S99.CrossRefGoogle Scholar

Lin, JS, O’Connor, E, Evans, CV, et al. Behavioral counseling to promote a healthy lifestyle in persons with cardiovascular Risk factors: a systematic review for the US Preventive Services Task Force. Ann Intern Med 2014; 161: 568–578.CrossRefGoogle Scholar

Robinson, JG, Goldberg, AC. Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association expert panel on familial hypercholesterolemia. J Clin Lipidol 2011; 5: S18–S29.CrossRefGoogle Scholar

Sacks, FM, Carey, VJ, Anderson, CAM, et al. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity. JAMA 2014; 312(23): 2531–2541.CrossRefGoogle ScholarPubMed

Foraker, RE, Pennell, M, Sprangers, P, et al. Effect of a low-fat or low-carbohydrate weight-loss diet on markers of cardiovascular risk among premenopausal women: a randomized trial. J Womens Health (Larchmt) 2014 Aug; 23(8): 675–680.CrossRefGoogle ScholarPubMed

Bazzano, LA, Hu, T, Reynolds, K, et al. Effects of low- carbohydrate and low-fat diets. Ann Intern Med 2014; 161: 309–331.CrossRefGoogle ScholarPubMed

Ito, MK, McGowan, MP, Moriarty, PM. Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association expert panel on familial hypercholesterolemia. J Clin Lipidol 2011; 5: S38–S45.CrossRefGoogle Scholar

Broekhuizen, K, van Poppel, MNM, Koppes, LL, et al. No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: result of a randomised controlled trial. BMC Research Notes 2012; 5: 181. DOI: 10.1186/1756-0050-5-181.CrossRefGoogle ScholarPubMed

National Cholesterol Education Program. Third report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). NIH Pub. No. 02–5215. Bethesda, MD: National Heart, Lung, and Blood Institute, 2002; 284 pages.Google Scholar

McKenney, JM. Pharmacologic characteristics of statins. Clin Cardiol 2003 Apr; 26(4 suppl 3): III 32–38.CrossRefGoogle ScholarPubMed

Ridker, PM. The JUPITER trial: results, controversies, and implications for prevention. Circ Cardiovasc Qual Outcomes 2009; 2: 279–285.CrossRefGoogle ScholarPubMed

Eapen, DJ, Valiani, K, Reddy, S, Sperling, L. Management of familial hypercholesterolemia during pregnancy: case series and discussion. J Clin Lipidol 2012; 6: 88–91.CrossRefGoogle ScholarPubMed

Vishwanath, R, Hemphill, LC. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy. J Clin Lipidol 2012; 8: 18–28.CrossRefGoogle Scholar

Nordestgaard, BG, Chapman, MJ, Humphries, SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Eu Heart J 2013; 34: 3478–3490.CrossRefGoogle ScholarPubMed